Bogdan Dumitriu, MD

Dr. Dumitriu is a hematology clinical fellow at the National Institutes of Health (NIH). Dr. Dumitriu studied at the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania. He was a postdoctoral fellow at the department of pharmacology and experimental therapeutics at the University of Maryland School of Medicine; the department of biomedical engineering at Cleveland Clinic, and the department of cell biology, also at Cleveland Clinic. Prior to joining NIH, he was with the department of internal medicine at Cleveland Clinic. Dr Dumitriu is the recipient of numerous honors and awards. He received a Postdoctoral Research Fellowship Award from the American Heart Association for 2006-2008, and most recently received the Arnold P. Gold Foundation Humanism and Excellence in Teaching Award. Dr. Dumitriu has been the author and co-author of numerous abstracts and articles published in peer-reviewed journals, including the Journal of Neurophysiology and PLoS One. He has also been a part of several clinical research clinical research: A type of research that involves individual persons or a group of people. There are three types of clinical research. Patient-oriented research includes clinical trials which test how a drug, medical device, or treatment approach works in people. Epidemiology or behavioral studies look at the… protocols as associate investigator and principal investigator including Treatment of T-Large Granular Lymphocytes Lymph proliferative Disorders with Alemtuzumab Alemtuzumab: Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade names Campath, MabCampath and Campath-1H, and in the treatment of multiple sclerosis as Lemtrada. It is also used in some conditioning regimens for… .